Skip to main content
    K

    Kiora Pharmaceuticals Inc (KPRX)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $0.98
    -0.25 (-20.16%)

    Market Cap: $5.44M

    Last updated: Nov 17, 2026 at 11:04 AM ET

    Kiora Pharmaceuticals Inc (KPRX) Stock Forecast

    Updated Nov 17, 2026. Estimates and ratings come from consensus analyst data.

    Analysts expect Kiora Pharmaceuticals (KPRX) to earn -$1.14 per share in the fiscal year ending Dec 31, 2026. Over the last 30 days, 1 estimate for the fiscal year ending Dec 31, 2026 was revised up and 0 down. For the fiscal year ending Dec 31, 2027, the EPS consensus is -$0.79.

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Annual Estimates

    From the first fiscal year below to the second, the EPS consensus shows a smaller loss.

    Fiscal year ending Dec 31, 2026
    -$1.14
    EPS consensus
    Fiscal year ending Dec 31, 2027
    -$0.79
    EPS consensus
    Next report
    Mar 23, 2027
    Estimated

    EPS range

    Fiscal year endingEPS consensusEPS rangeEPS analysts
    Dec 31, 2026-$1.14-$1.14 to -$1.141
    Dec 31, 2027-$0.79-$0.79 to -$0.791

    Quarterly Estimates

    The EPS consensus rises from -$0.43 for the quarter ending Dec 31, 2026 to -$0.13 for the quarter ending Mar 31, 2027.

    Quarter endingEPS consensusEPS rangeEPS analysts
    Dec 31, 2026-$0.43N/A3
    Mar 31, 2027-$0.13-$0.13 to -$0.131

    Estimate Revisions

    Across the 3 periods below, the last 30 days brought 2 upward and 1 downward EPS revisions.

    PeriodUp 30 daysDown 30 days
    Fiscal year ending Dec 31, 202610
    Fiscal year ending Dec 31, 202710
    Quarter ending Mar 31, 202701

    EPS Trend

    Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has improved from -$2.66.

    PeriodNow7 days ago30 days ago60 days ago90 days agoChange
    Fiscal year ending Dec 31, 2026-$1.14-$1.67-$1.67-$1.67-$2.66N/A
    Fiscal year ending Dec 31, 2027-$0.79-$1.41-$1.41-$1.41-$1.97N/A
    Quarter ending Mar 31, 2027-$0.13-$0.36-$0.36-$0.36N/AN/A

    Frequently Asked Questions About KPRX

    What is the KPRX stock forecast?

    Consensus analyst estimates put Kiora Pharmaceuticals's EPS at -$1.14 for the fiscal year ending Dec 31, 2026.

    What EPS do analysts expect from KPRX next year?

    For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is -$1.14, with estimates from -$1.14 to -$1.14 from 1 analyst. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is -$0.79, with estimates from -$0.79 to -$0.79 from 1 analyst.

    How many analysts cover KPRX?

    1 analyst estimates EPS for Kiora Pharmaceuticals for the fiscal year ending Dec 31, 2026.